These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 8615485)

  • 41. An initial multicenter, randomized controlled trial on the safety and efficacy of acadesine in patients undergoing coronary artery bypass graft surgery. SPI Research Group.
    Leung JM; Stanley T; Mathew J; Curling P; Barash P; Salmenpera M; Reves JG; Hollenberg M; Mangano DT
    Anesth Analg; 1994 Mar; 78(3):420-34. PubMed ID: 7818622
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Multicentre double-blind randomized controlled trial of perhexiline as a metabolic modulator to augment myocardial protection in patients with left ventricular hypertrophy undergoing cardiac surgery.
    Senanayake EL; Howell NJ; Ranasinghe AM; Drury NE; Freemantle N; Frenneaux M; Oelofse T; Green D; Wilson IC; Rooney SJ; Mascaro J; Graham TR; Bhudia S; Lewis M; Pagano D
    Eur J Cardiothorac Surg; 2015 Sep; 48(3):354-62. PubMed ID: 25538197
    [TBL] [Abstract][Full Text] [Related]  

  • 43. High-dose insulin administration improves left ventricular function after coronary artery bypass graft surgery.
    Sato H; Hatzakorzian R; Carvalho G; Sato T; Lattermann R; Matsukawa T; Schricker T
    J Cardiothorac Vasc Anesth; 2011 Dec; 25(6):1086-91. PubMed ID: 21757376
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effects of trimetazidine on the contractile response of chronically dysfunctional myocardium to low-dose dobutamine in ischaemic cardiomyopathy.
    Belardinelli R; Purcaro A
    Eur Heart J; 2001 Dec; 22(23):2164-70. PubMed ID: 11913478
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Myocardial release of malondialdehyde and purine compounds during coronary bypass surgery.
    Lazzarino G; Raatikainen P; Nuutinen M; Nissinen J; Tavazzi B; Di Pierro D; Giardina B; Peuhkurinen K
    Circulation; 1994 Jul; 90(1):291-7. PubMed ID: 8026011
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The protective effects of trimetazidine on testicular ischemia and reperfusion injury in rats.
    Pekcetin C; Ergur BU; Kiray M; Bagriyanik A; Tugyan K; Erbil G; Ozogul C
    Pediatr Surg Int; 2007 Nov; 23(11):1113-8. PubMed ID: 17704922
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effect of free fatty acid inhibition on silent and symptomatic myocardial ischemia in diabetic patients with coronary artery disease.
    Marazzi G; Wajngarten M; Vitale C; Patrizi R; Pelliccia F; Gebara O; Pierri H; Ramires JA; Volterrani M; Fini M; Rosano GM
    Int J Cardiol; 2007 Aug; 120(1):79-84. PubMed ID: 17134770
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Beta-blockade versus Buckberg blood-cardioplegia in coronary bypass operation.
    Kuhn-Régnier F; Natour E; Dhein S; Dapunt O; Geissler HJ; LaRosé K; Görg C; Mehlhorn U
    Eur J Cardiothorac Surg; 1999 Jan; 15(1):67-74. PubMed ID: 10077376
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Lipid peroxidation after cold storage and normothermic reperfusion: the effect of trimetazidine.
    Hauet T; Baumert H; Mothes D; Germonville T; Caritez JC; Carretier M; Journe F; Eugene M; Tillement JP
    Transpl Int; 1998; 11 Suppl 1():S408-9. PubMed ID: 9665028
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Inhibition of complement activation by pexelizumab reduces death in patients undergoing combined aortic valve replacement and coronary artery bypass surgery.
    Carrier M; Ménasché P; Levy JH; Newman MF; Taylor KM; Haverich A; Chen JC; Shernan SK; Van de Werf F; van der Laan M; Todaro TG; Adams PX; Verrier ED
    J Thorac Cardiovasc Surg; 2006 Feb; 131(2):352-6. PubMed ID: 16434264
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Clinical-pharmacoeconomic aspects of trimetazidine modified release use in patients with ischemic heart disease undergoing coronary artery bypass grafting].
    Lopatin IuM; Dronova EP
    Kardiologiia; 2009; 49(2):15-21. PubMed ID: 19254211
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effect of Levosimendan on Low Cardiac Output Syndrome in Patients With Low Ejection Fraction Undergoing Coronary Artery Bypass Grafting With Cardiopulmonary Bypass: The LICORN Randomized Clinical Trial.
    Cholley B; Caruba T; Grosjean S; Amour J; Ouattara A; Villacorta J; Miguet B; Guinet P; Lévy F; Squara P; Aït Hamou N; Carillion A; Boyer J; Boughenou MF; Rosier S; Robin E; Radutoiu M; Durand M; Guidon C; Desebbe O; Charles-Nelson A; Menasché P; Rozec B; Girard C; Fellahi JL; Pirracchio R; Chatellier G;
    JAMA; 2017 Aug; 318(6):548-556. PubMed ID: 28787507
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The effect of trimetazidine on C-reactive protein, cytokines and adhesion molecules in the course of acute myocardial infarction.
    Pudil R; Pidrman V; Krejsek J; Gregor J; Tichý M; Andrýs C; Drahosová M; Bláha V
    Acta Medica (Hradec Kralove); 2001; 44(4):135-40. PubMed ID: 11836849
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Reduction of oxidative stress does not affect recovery of myocardial function: warm continuous versus cold intermittent blood cardioplegia.
    Biagioli B; Borrelli E; Maccherini M; Bellomo G; Lisi G; Giomarelli P; Sani G; Toscano M
    Heart; 1997 May; 77(5):465-73. PubMed ID: 9196419
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Trimetazidine improves recovery during reperfusion in isolated rat hearts after prolonged ischemia.
    Ikizler M; Dernek S; Sevin B; Kural T
    Anadolu Kardiyol Derg; 2003 Dec; 3(4):303-8. PubMed ID: 14675878
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effect of 48-h intravenous trimetazidine on short- and long-term outcomes of patients with acute myocardial infarction, with and without thrombolytic therapy; A double-blind, placebo-controlled, randomized trial. The EMIP-FR Group. European Myocardial Infarction Project--Free Radicals.
    Eur Heart J; 2000 Sep; 21(18):1537-46. PubMed ID: 10973768
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Nonsynergistic effects of trimetazidine and selenium combination therapy on renal ischemic-reperfusion injury in rats.
    Karayaylali I; Emre M; Seyrek N; Yildiz SM; Erdogan S; Balal M; Paydas S; Tuncer I; Alparslan N
    Adv Ther; 2004; 21(1):47-60. PubMed ID: 15191157
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effectiveness of prophylactic levosimendan in patients with impaired left ventricular function undergoing coronary artery bypass grafting: a randomized pilot study.
    Anastasiadis K; Antonitsis P; Vranis K; Kleontas A; Asteriou C; Grosomanidis V; Tossios P; Argiriadou H
    Interact Cardiovasc Thorac Surg; 2016 Nov; 23(5):740-747. PubMed ID: 27378790
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Myocardial protection during percutaneous transluminal coronary angioplasty: effects of trimetazidine.
    Kober G; Buck T; Sievert H; Vallbracht C
    Eur Heart J; 1992 Aug; 13(8):1109-15. PubMed ID: 1505561
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effect of N-acetylcysteine in attenuating ischemic reperfusion injury in patients undergoing coronary artery bypass grafting with cardiopulmonary bypass.
    Prabhu A; Sujatha DI; Kanagarajan N; Vijayalakshmi MA; Ninan B
    Ann Vasc Surg; 2009; 23(5):645-51. PubMed ID: 19467834
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.